Khalid Islam

This profile gathers the share dealings of Khalid Islam in Fennec Pharmaceuticals Inc. Between 28 April 2014 and 10 June 2026, the trades on record add up to 6 filings.

Purchases make up the whole of the open-market record (4 purchases, €297k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 option exercise.

A typical purchase (the median) is worth €36k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 11 June 2026 with an option exercise (€135k) in Fennec Pharmaceuticals Inc. The latest purchase dates back some time: it was published 1,090 days ago, on 16 November 2023. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.